Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Food and Drug Administration on Monday declined to approve Atara Biotherapeutics' cell therapy for a rare form of blood ...
Food and Drug Administration commissioner Marty Makary's flagship effort to overhaul how the agency reviews drugs is facing ...
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare ...
Martin Makary, commissioner of the Food and Drug Administration, on the push against ultra processed foods and added sugar, ...
11hon MSN
Recall of cheese products upgraded to highest danger level over Listeria-causing bacteria: FDA
The FDA announced that a recall of cheese products has been upgraded to the most serious risk category after testing positive ...
Market Realist on MSN
FDA says a popular food item sold in 26 states has been recalled — return ASAP for full refund
The recall was issued by McCain Foods USA Inc, which recalled 40,000 cases of two tater tot brands. The affected products ...
The Food and Drug Administration has made some progress in creating a framework to carry out the Food Safety Modernization ...
The U.S. Food and Drug Administration (FDA) has still not fully implemented the foodborne illness provisions of the Food ...
FDA officials told GAO that competing priorities and an agency reorganization in late 2024 have slowed progress, estimating ...
The FDA declined to approve EBVALLO (tabelecleucel), Atara’s treatment for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) in patients who have received prior ...
Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback